Biotech
BioMarin Pharmaceutical
BioMarin Pharmaceutical raises $20B Public at $22B valuation
$20B
Total Raised
Public
Latest Round
1997
Founded
3500+
Employees
770 Lindaro Street, San Rafael, CA 94901
1 min read
Quick Facts
Valuation
$22B
Latest Round Size
$20B
Latest Round Date
January 2024
BioMarin Pharmaceutical: Public Funding Round
BioMarin Pharmaceutical has successfully raised $20B in Public funding, reaching a valuation of $22B.
Company Overview
Biotechnology company
Funding Details
The Public round was led by Public.
Company Information
- Headquarters: 770 Lindaro Street, San Rafael, CA 94901
- Founded: 1997
- Employees: 3500+
- Category: Biotech
Investment
BioMarin Pharmaceutical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Public: Verified investor in Public
Key Investors
Public
Lead Investor
Verified investor in Public
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M